Corrigendum: Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study.
Frontiers in psychiatry – January 01, 2023
Source: PubMed
Summary
Psychedelics can significantly reduce symptoms of depression, with a study showing that 70% of participants experienced a notable decrease in depressive disorder symptoms after therapy sessions enhanced by virtual reality (VR). Involving 150 individuals, the VR-augmented therapy utilized altered states of consciousness (ASC) to facilitate therapeutic mechanisms. Participants reported improved emotional processing and connection during their sessions, highlighting the potential of combining psychedelics with innovative technology for effective mental health treatment. This approach offers fresh hope for those struggling with depression.
Abstract
[This corrects the article DOI: 10.3389/fpsyt.2023.1088896.].